Clinical Division of Gynecologic Endocrinology and Reproductive Medicine, Medical University of Vienna, Vienna, Austria.
Department of Laboratory Medicine and Institute of Immunology, Medical University Vienna, Vienna, Austria.
Front Endocrinol (Lausanne). 2023 May 16;14:1173422. doi: 10.3389/fendo.2023.1173422. eCollection 2023.
Polycystic ovary syndrome (PCOS) is linked to an elevated risk of psychological disorders, decreased quality of life and emotional distress. Serum cortisol as a potential stress marker has been found to be increased in women with PCOS. The aim of this study was to evaluate both saliva stress markers and subjective psychological distress in women with PCOS.
In a prospective case-control study, 31 PCOS women and 31 healthy controls were included. Salivary cortisol, and metanephrines were collected in the morning and in the evening. Emotional distress and quality of life were assessed by means of the Perceived Stress Scale (PSS-10) and the Short Form-36 (SF-36). Multivariable generalized linear models were applied to test the influence of various parameters on numerical outcome parameters.
After correction for age and body mass index (BMI), there were no statistically significant differences of salivary biomarkers between PCOS women and healthy controls (p>0.05). PCOS patients revealed significantly higher increased PSS total scores and lower quality of life in all SF-36 modules apart from pain (p< 0.05). The PSS total score was positively correlated to prolactin in PCOS women (r= 0.450; p= 0.011). In overweight/obese PCOS patients, a higher BMI, a higher Ferriman Gallwey score and higher age significantly predicted the PSS total score (p< 0.05).
Stress measured by salivary biomarkers did not differ between PCOS women and healthy controls, whereas stress scores evaluated by questionnaires were significantly greater in women with PCOS. A higher BMI, hirsutism and a higher age seem to be the main modulators of subjective stress in PCOS. Prolactin might serve as a biomarker for chronic stress in PCOS women.
多囊卵巢综合征(PCOS)与心理障碍、生活质量下降和情绪困扰的风险增加有关。研究发现,多囊卵巢综合征妇女的血清皮质醇作为潜在的应激标志物升高。本研究旨在评估多囊卵巢综合征妇女的唾液应激标志物和主观心理困扰。
在一项前瞻性病例对照研究中,纳入 31 名多囊卵巢综合征妇女和 31 名健康对照者。分别在早上和晚上采集唾液皮质醇和甲氧基肾上腺素。采用压力知觉量表(PSS-10)和简明健康状况调查问卷(SF-36)评估情绪困扰和生活质量。采用多变量广义线性模型检验各种参数对数值结果参数的影响。
校正年龄和体重指数(BMI)后,多囊卵巢综合征妇女和健康对照者之间的唾液生物标志物无统计学差异(p>0.05)。多囊卵巢综合征患者的 PSS 总分明显升高,除疼痛外,所有 SF-36 模块的生活质量均降低(p<0.05)。PSS 总分与多囊卵巢综合征妇女的催乳素呈正相关(r=0.450;p=0.011)。在超重/肥胖的多囊卵巢综合征患者中,更高的 BMI、更高的 Ferriman-Gallwey 评分和更高的年龄显著预测 PSS 总分(p<0.05)。
唾液生物标志物测量的应激在多囊卵巢综合征妇女和健康对照者之间无差异,而问卷评估的应激评分在多囊卵巢综合征妇女中显著更高。更高的 BMI、多毛症和更高的年龄似乎是多囊卵巢综合征患者主观应激的主要调节剂。催乳素可能是多囊卵巢综合征妇女慢性应激的生物标志物。